Anne C. Spaulding

TL;DR: Cutting HIV seroprevalence among those admitted to jails and prisons, prolonged survival and aging of the US population with HIV/AIDS beyond the crime-prone years, and success with discharge planning programs targeting HIV-infected prisoners could explain the declining concentration of the epidemic among correctional populations.

TL;DR: Flattening the Curve for Incarcerated Populations People caught up in the U.S. justice system have already been affected by SARS-CoV-2, and improved preparation is essential to minimizing the impact of the virus.

TL;DR: The results suggest that the low mortality inside prisons can be explained by the rarity of deaths unlikely to occur in the context of incarceration and compassionate releases of moribund patients.

TL;DR: A link between area HIV specialists and correctional health care providers is an important partnership for ensuring that HIV-infected patients have optimal care both inside prison and after release.

TL;DR: 5 distinct factors contribute significantly to treatment outcomes for released prisoners infected with HIV and have profound individual and public health implications, including adaptation of case management services to facilitate linkage to care, continuity of cART, treatment of substance use disorders, and continuity of mental illness treatment are focused on.